Get startedLog in
    Picture of China Resources Pharmaceutical logo

    3320 — China Resources Pharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareBalancedLarge CapContrarian
    All News

    Brief: China Resources Pharmaceutical Reports HY Net Profit Attributable For CR Double-Crane RMB975.5 Million

    Picture of China Resources Pharmaceutical logoChina Resources Pharmaceutical
    22/08/2025 10:28
    Aug 22 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:

HY NET PROFIT ATTRIBUTABLE FOR CR DOUBLE-CRANE RMB975.5 MILLION

CR DOUBLE-CRANE  PROPOSED TO DISTRIBUTE CASH DIVIDEND OF RMB1 (INCLUSIVE OF TAX) FOR EVERY 10  SHARES

HY REVENUE FOR CR DOUBLE-CRANE RMB 5.74 BILLION

Further company coverage: 3320.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on China Resources Pharmaceutical

    See all news